QTERNMET XR

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   May 02, 2019

   7 yr 3 mo ago

2. Patent 6515117 expires

   Listed drug substance patent expiration.

   Oct 04, 2025

   9 mo ago

3. Patent 6515117*PED expires

   Listed listed patent expiration.

   Apr 04, 2026

   3 mo ago

4. Today

5. Patent 8501698 expires

   Listed drug product patent expiration.

   Jun 20, 2027

   in 1 yr

6. Patent 8501698*PED expires

   Listed listed patent expiration.

   Dec 20, 2027

   in 1 yr 6 mo

7. Patent 8716251 expires

   Listed drug product patent expiration.

   Mar 21, 2028

   in 1 yr 9 mo

8. Patent 8716251*PED expires

   Listed listed patent expiration.

   Sep 21, 2028

   in 2 yr 4 mo

9. Patent 7919598 expires

   Listed drug substance patent expiration.

   Dec 16, 2029

   in 3 yr 7 mo

10. Patent 7919598*PED expires

    Listed listed patent expiration.

    Jun 16, 2030

    in 4 yr 1 mo

11. Patent 9616028 expires

    Listed drug product patent expiration.

    Nov 12, 2030

    in 4 yr 6 mo

12. Patent 9616028*PED expires

    Listed listed patent expiration.

    May 12, 2031

    in 5 yr

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (10)